Baxter International (BAX) Peer Comparison
$25.48
As on 01-Sep-2026 16:00EDT
Market cap
$13,654 Mln
Revenue (TTM)
$11,470 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0.8 %
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
13,654 | 26,879 | 11,194 | 11,502 | 10,065 |
Revenue ($ Mln) |
11,470 | 17,664 | 4,140 | 3,145 | 3,054 |
Net Profit ($ Mln) |
-1,063.00 | 1,114.00 | 413.58 | 535.46 | 375.30 |
Net Margin (%) |
-9.27 | 6.31 | 9.99 | 17.03 | 12.29 |
RoE (%) |
-17.24 | 9.93 | 9.99 | 11.46 | 25.55 |
Price to Earnings |
-- | 20.99 | 27.41 | 22.54 | 27.23 |
Price-To-Book |
2.22 | 2.04 | 2.67 | 2.49 | 6.99 |
Income Statement ($ Mln)
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
11,470.00 | 17,664.00 | 4,139.53 | 3,144.90 | 3,053.50 |
|
Cost of Revenue
|
8,020.00 | 9,551.00 | 1,387.59 | 989.14 | 883.10 |
|
Gross Profit
|
3,379.00 | 8,058.00 | 2,756.90 | 1,981.10 | 1,939.90 |
|
Operating Expenses
|
3,724.00 | 6,392.00 | 2,200.16 | 1,504.66 | 1,654.50 |
|
Operating Profit (EBIT)
|
-274.00 | 1,721.00 | 551.86 | 652.69 | 515.80 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-483.00 | 1,477.00 | 568.91 | 664.95 | 494.70 |
|
Provision for Tax
|
485.00 | 364.00 | 155.33 | 129.49 | 119.30 |
|
Profit after Tax (Net Income)
|
-1,063.00 | 1,114.00 | 413.58 | 535.46 | 375.30 |
|
Minority Interest
|
0.00 | -2.00 | 0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
-1,174.00 | 579.00 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,206.00 | 11,447.00 | 4,232.45 | 4,768.60 | 1,422.20 |
|
Minority Interest
|
0.00 | -2.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
10,021.00 | 7,802.00 | 276.53 | 240.31 | 998.70 |
|
Current Liabilities
|
3,591.00 | 7,423.00 | 1,908.60 | 479.35 | 744.20 |
|
Total Liabilities
|
20,055.00 | 26,944.00 | 6,233.69 | 5,302.76 | 3,190.40 |
Assets ($ Mln)
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
12,802.00 | 17,371.00 | 3,754.53 | 3,272.75 | 1,316.00 |
|
Current Assets
|
6,989.00 | 9,330.00 | 2,663.05 | 2,215.51 | 1,849.10 |
|
Total Assets
|
20,055.00 | 26,944.00 | 6,233.69 | 5,302.76 | 3,190.40 |
|
Total Debt*
|
9,667.00 | 7,465.00 | 120.84 | 111.19 | 948.40 |
|
Net Current Assets
|
3,398.00 | 1,907.00 | 754.45 | 1,736.17 | 1,104.90 |
Cashflow ($ Mln)
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
845.00 | 1,162.00 | 593.22 | 753.45 | 569.30 |
|
Cash Flow from Investing Activities
|
2,841.00 | -737.00 | -112.45 | -355.01 | -222.70 |
|
Cash from Financing Activities
|
-4,216.00 | 107.00 | -464.58 | -679.16 | -595.30 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-5.24 | 4.64 | 10.09 | 11.44 | 9.50 |
|
ROE (%)
|
-17.24 | 9.93 | 9.99 | 11.46 | 25.55 |
|
ROA (%)
|
-4.49 | 3.29 | 5.00 | 9.43 | 8.97 |
|
EBIT Margin (%)
|
-1.77 | 10.30 | 15.19 | 15.11 | 13.73 |
|
Net Margin (%)
|
-9.27 | 6.31 | 9.99 | 17.03 | 12.29 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
5.36 | -1.08 | 4.41 | 19.74 | 29.41 |
|
EBIT Growth (%)
|
-734.38 | 59.79 | -3.03 | 36.96 | 30.76 |
|
Net Profit Growth (%)
|
-585.81 | 587.65 | -5.49 | 50.14 | 58.96 |
|
EPS Growth (%)
|
-571.39 | 579.15 | -2.80 | 50.51 | 66.81 |
|
Book Value Growth (%)
|
-15.87 | 8.94 | 9.63 | 9.65 | -1.05 |
Valuation Ratios
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-10.26 | 29.23 | 27.31 | 22.27 | 81.29 |
|
Price / Book Value
|
1.60 | 2.39 | 2.77 | 2.62 | 13.26 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
23.32 | 11.92 | 13.35 | 15.81 | 38.36 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
1.39 | 0.55 | 0.00 | 0.00 | 0.65 |
|
Short term debt to equity ratio
|
0.14 | 0.10 | 0.01 | 0.00 | 0.01 |
|
Current Ratio
|
1.95 | 1.26 | 1.40 | 4.62 | 2.48 |
|
Quick Ratio
|
1.32 | 0.82 | 1.28 | 2.93 | 1.83 |
|
Interest Coverage
|
-0.65 | 5.06 | 364.75 | 97.52 | 8.80 |
Operating Efficiency Ratios
| Baxter International (BAX) | Koninklijke Philips N.V. NY Registry Shares - ADR | Align Technology (ALGN) | Globus Medical (GMED) | Insulet (PODD) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.18 | 20.36 | 27.74 | 23.51 | 19.28 |
|
Asset Turnover
|
0.48 | 0.52 | 0.50 | 0.55 | 0.73 |
|
Receivable days
|
59.48 | 73.75 | 99.00 | 82.15 | 59.51 |
|
Inventory Days
|
99.33 | 113.36 | 68.68 | 270.47 | 209.92 |
|
Payable days
|
45.67 | 70.18 | 32.89 | 33.17 | 22.54 |
|
Cash Conversion Cycle
|
113.14 | 116.92 | 134.79 | 319.45 | 246.89 |